Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""HYPEREOSINOPHILIC syndrome"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 250
Tytuł:
Epidemiology and prognostic nomogram for chronic eosinophilic leukemia: a population-based study using the SEER database.
Autorzy:
Wang J; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, China.
Lin M; Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, China.
Wang F; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, Hubei, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 26; Vol. 14 (1), pp. 4594. Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:
Journal Article
MeSH Terms:
Hypereosinophilic Syndrome*
Leukemia*/diagnosis
Leukemia*/epidemiology
Nomograms*
Female ; Humans ; Male ; Middle Aged ; Prognosis ; Research ; SEER Program
SCR Disease Name:
Pdgfra-Associated Chronic Eosinophilic Leukemia
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
An 85-Year-Old Man with Fever, Dyspnea, and Dry Cough Diagnosed with Idiopathic Hypereosinophilic Syndrome, Successfully Treated with High-Dose Corticosteroids.
Autorzy:
Goyal P; Department of Cardiology, Dayanand Medical College & Hospital, Ludhiana, India.
Chhabra ST; Department of Cardiology, Dayanand Medical College & Hospital, Ludhiana, India.
Tandon R; Department of Cardiology, Dayanand Medical College & Hospital, Ludhiana, India.
Jaiswal B; Department of Cardiology, Dayanand Medical College & Hospital, Ludhiana, India.
Sharma N; Department of Cardiology, Dayanand Medical College & Hospital, Ludhiana, India.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2023 Dec 11; Vol. 24, pp. e941241. Date of Electronic Publication: 2023 Dec 11.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Hypereosinophilic Syndrome*/complications
Hypereosinophilic Syndrome*/diagnosis
Hypereosinophilic Syndrome*/drug therapy
Aged, 80 and over ; Humans ; Male ; Adrenal Cortex Hormones/therapeutic use ; Cough/etiology ; Cough/complications ; Dyspnea/etiology ; Lung
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
ETV6::ABL1 -Positive Myeloid Neoplasm: A Case of a Durable Response to Imatinib Mesylate without Additional or Previous Treatment.
Autorzy:
Bochicchio MT; Biosciences Laboratory, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, FC, Italy.
Marconi G; Hematology Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, FC, Italy.
Baldazzi C; Istituto di Ematologia 'Seràgnoli', IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, BO, Italy.
Bandini L; Istituto di Ematologia 'Seràgnoli', IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, BO, Italy.
Ruggieri F; Biosciences Laboratory, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, FC, Italy.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40100 Bologna, BO, Italy.
Lucchesi A; Hematology Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, FC, Italy.
Agostinelli C; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40100 Bologna, BO, Italy.; Haematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, BO, Italy.
Sabattini E; Haematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, BO, Italy.
Orsatti A; Haematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, BO, Italy.
Ferrari A; Biosciences Laboratory, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, FC, Italy.
Capirossi G; Biosciences Laboratory, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, FC, Italy.
Servili C; Biosciences Laboratory, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, FC, Italy.
Ghelli Luserna di Rorà A; Fondazione Pisana per la Scienza ONLUS, 56017 San Giuliano Terme, PI, Italy.
Martinelli G; Scientific Directorate, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, FC, Italy.
Simonetti G; Biosciences Laboratory, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, FC, Italy.
Rosti G; Hematology Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, FC, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 21; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 21.
Typ publikacji:
Case Reports
MeSH Terms:
Myeloproliferative Disorders*
Hypereosinophilic Syndrome*
Neoplasms*
Female ; Humans ; Middle Aged ; Imatinib Mesylate/therapeutic use ; Protein Kinase Inhibitors ; Cytogenetics ; Proto-Oncogene Proteins c-ets/genetics
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Low-dose anti-IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance.
Autorzy:
Caminati M; Department of Medicine, University of Verona & AOUI Verona, Policlinico GB Rossi, Piazzale L.A. Scuro, 10, 37134, Verona, Italy. .
Maule M; Asthma Center and Allergy Unit, AOUI Verona, Policlinico GB Rossi, Verona, Italy.
Benoni R; Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Micheletto C; Respiratory Unit, AOUI Verona, Policlinico GB Rossi, Verona, Italy.
Tecchio C; Haematology Unit, AOUI Verona, Policlinico GB Rossi, Verona, Italy.
Vaia R; Asthma Center and Allergy Unit, AOUI Verona, Policlinico GB Rossi, Verona, Italy.
De Franceschi L; Department of Medicine, University of Verona & AOUI Verona, Policlinico GB Rossi, Piazzale L.A. Scuro, 10, 37134, Verona, Italy.
Guarnieri G; Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padova, Padua, Italy.
Vianello A; Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padova, Padua, Italy.
Senna G; Department of Medicine, University of Verona & AOUI Verona, Policlinico GB Rossi, Piazzale L.A. Scuro, 10, 37134, Verona, Italy.; Asthma Center and Allergy Unit, AOUI Verona, Policlinico GB Rossi, Verona, Italy.
Pokaż więcej
Źródło:
Orphanet journal of rare diseases [Orphanet J Rare Dis] 2023 Sep 26; Vol. 18 (1), pp. 302. Date of Electronic Publication: 2023 Sep 26.
Typ publikacji:
Letter
MeSH Terms:
Precision Medicine*
Hypereosinophilic Syndrome*/drug therapy
Female ; Humans ; Middle Aged ; Aged ; Prednisone/therapeutic use
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Contrast Echocardiography with Different Probes: A New Attempt at the Follow-Up of Apical Thrombus in Loeffler Endocarditis.
Autorzy:
Lou J; Department of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Clinical Research Center for Medical Imaging in Hubei Province, Wuhan, China; Hubei Province Key Laboratory of Molecular Imaging, Wuhan, China.
Wu W; Department of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Clinical Research Center for Medical Imaging in Hubei Province, Wuhan, China; Hubei Province Key Laboratory of Molecular Imaging, Wuhan, China.
Chen X; Department of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Clinical Research Center for Medical Imaging in Hubei Province, Wuhan, China; Hubei Province Key Laboratory of Molecular Imaging, Wuhan, China.
Xie M; Department of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Clinical Research Center for Medical Imaging in Hubei Province, Wuhan, China; Hubei Province Key Laboratory of Molecular Imaging, Wuhan, China.
Lv Q; Department of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Clinical Research Center for Medical Imaging in Hubei Province, Wuhan, China; Hubei Province Key Laboratory of Molecular Imaging, Wuhan, China.
Pokaż więcej
Źródło:
Anatolian journal of cardiology [Anatol J Cardiol] 2023 Jul 03; Vol. 27 (7), pp. E23-E24. Date of Electronic Publication: 2023 Jun 07.
Typ publikacji:
Journal Article
MeSH Terms:
Thrombosis*/diagnostic imaging
Hypereosinophilic Syndrome*/diagnosis
Hypereosinophilic Syndrome*/diagnostic imaging
Humans ; Follow-Up Studies ; Echocardiography
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes.
Autorzy:
Groh M; Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France. .; Department of Internal Medicine, Hôpital Foch, Suresnes, France. .; Inserm, U1286 - INFINITE - Institute for Translational Research in Inflammation, University of Lille, CHU Lille, Lille, France. .; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France. .
Rohmer J; Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.; Department of Internal Medicine, University of Sorbonne-Paris-Cité, APHP, CHU Bichat, Paris, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Etienne N; Department of Infectious Diseases and Tropical Medicine, University of Sorbonne-Paris-Cité, APHP, CHU Necker-Enfants Malades, Paris, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Abou Chahla W; Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.; Department of Pediatric Hematology, University of Lille, CHU Lille, Lille, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Baudet A; Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.; Department of Internal Medicine, CH Annecy Genevois, Metz Tessy, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Chan Hew Wai A; Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.; Department of Pharmacology, Hôpital Foch, Suresnes, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Chenivesse C; Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.; CNRS, Inserm, Institut Pasteur de Lille, U1019-UMR9017-CIIL-Centre d'Infection et d'Immunité de Lille, University of Lille, CHU Lille, Lille, France.; CRISALIS (Clinical Research Initiative in Severe Asthma: a Lever for Innovation and Science), F-CRIN Network, INSERM US015, Toulouse, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Clisson Rusek I; Association Pour l'Information sur les Maladies à Eosinophiles, Bourg-la-Reine, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Cottin V; Department of Respiratory Medicine, Hôpital Louis Pradel, UMR754 INRAE, University of Lyon 1, Hospices Civils de Lyon, Lyon, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Decamp M; Department of Cytogenetics, CHU de Caen, Caen, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
De Groote P; Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.; Department of Cardiology, University of Lille, CHU Lille, Lille, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Delahousse F; Nantes, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Duployez N; Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.; Laboratory of Hematology, University of Lille, CHU Lille, Lille, France.; CNRS, Inserm, IRCL, UMR9020 - UMR1277 - Canther - Cancer Heterogeneity, Plasticity and Resistance to Therapies, 59000, Lille, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Faguer S; Department of Nephrology and Organ Transplantation, University of Paul Sabatier Toulouse III, CHU Toulouse, Toulouse, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Gottrand F; Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.; Inserm, U1286 - INFINITE - Institute for Translational Research in Inflammation, University of Lille, CHU Lille, Lille, France.; Division of Gastroenterology, Hepatology and Nutrition, Department of Paediatrics, Jeanne de Flandre Children's Hospital, University of Lille, CHU Lille, Lille, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Huang F; Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.; Department of Cardiology, Hôpital Foch, Suresnes, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Leblanc T; Pediatric Hematology and Immunology Department, University Sorbonne-Paris-Cité, APHP, CHU Robert Debré, Paris, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Magnan A; Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.; Department of Respiratory Medicine, Hôpital Foch, Suresnes, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Martin T; Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.; Department of Internal Medicine, CHU Strasbourg, Strasbourg, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Mortuaire G; Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.; Inserm, U1286 - INFINITE - Institute for Translational Research in Inflammation, University of Lille, CHU Lille, Lille, France.; Otorhinolaryngology-Head and Neck Department, University of Lille, CHU de Lille, Lille, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Néel A; Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.; Department of Internal Medicine, CHU Nantes, Nantes, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Paris L; Department of Parasitology and Mycology, Sorbonne Université, APHP, CHU Pitié-Salpêtrière, Paris, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Petit A; Department of Hematology and Pediatric Oncology, Sorbonne Université, APHP, CHU Armand Trousseau, Paris, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Rossignol J; Department of Hematology, University of Sorbonne-Paris-Cité, APHP, CHU Necker, Paris, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Schleinitz N; Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.; Department of Internal Medicine, APHM, CHU La Timone, Marseille, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Soret-Dulphy J; Centre d'Investigation Clinique, University of Sorbonne-Paris-Cité, AP-HP, CHU St-Louis, Paris, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Staumont-Salle D; Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.; Department of Dermatology, University of Lille, CHU de Lille, Lille, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Terrier B; Department of Internal Medicine, University of Sorbonne-Paris-Cité, AP-HP, Paris, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Terriou L; Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.; Department of Internal Medicine and Clinical Immunology, University of Lille, CHU de Lille, Lille, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Viallard JF; Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.; Department of Internal Medicine, CHU de Bordeaux, Bordeaux, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Lefèvre G; Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.; Inserm, U1286 - INFINITE - Institute for Translational Research in Inflammation, University of Lille, CHU Lille, Lille, France.; Department of Internal Medicine and Clinical Immunology, University of Lille, CHU de Lille, Lille, France.; Department of Internal Medicine, CHU de Bordeaux, Bordeaux, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Kahn JE; Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.; Institut d'Immunologie, University of Lille, CHU de Lille, Lille, France.; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
Pokaż więcej
Źródło:
Orphanet journal of rare diseases [Orphanet J Rare Dis] 2023 Apr 30; Vol. 18 (1), pp. 100. Date of Electronic Publication: 2023 Apr 30.
Typ publikacji:
Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't
MeSH Terms:
Hypereosinophilic Syndrome*/therapy
Hypereosinophilic Syndrome*/drug therapy
Adult ; Child ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cerebral watershed infarctions as a presentation of idiopathic hypereosinophilic syndrome: a case report.
Autorzy:
Wang X; Department of Geriatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China.
Hou X; Department of Geriatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China.; Department of Geriatric Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China.
Lv R; Department of Geriatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China.
Chen J; Department of Geriatric Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China.
Zhang F; Department of Geriatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China.; Department of Geriatric Hematology and Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China.
Yin Q; Department of Geriatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China. .; Department of Geriatric Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China. .
Pokaż więcej
Źródło:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2023 Apr; Vol. 44 (4), pp. 1429-1431. Date of Electronic Publication: 2022 Dec 01.
Typ publikacji:
Case Reports; Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Cerebral Infarction*/complications
Cerebral Infarction*/diagnostic imaging
Hypereosinophilic Syndrome*/complications
Hypereosinophilic Syndrome*/diagnosis
Humans
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Detection of FIP1L1-PDGFRA fusion gene-positive cells in the skin lesion of a patient with hypereosinophilic syndrome.
Autorzy:
Kitayama S; Department of Dermatology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.
Makino T; Department of Dermatology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.
Yoto A; Department of Dermatology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.
Mori S; Department of Dermatology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.
Furukawa F; Department of Dermatology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.
Torai R; Department of Dermatology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.
Mizawa M; Department of Dermatology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.
Shimizu T; Department of Dermatology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2023 Mar 22; Vol. 48 (4), pp. 364-367.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Hypereosinophilic Syndrome*/diagnosis
Hypereosinophilic Syndrome*/genetics
Hypereosinophilic Syndrome*/pathology
Male ; Humans ; Aged ; In Situ Hybridization, Fluorescence ; Receptor, Platelet-Derived Growth Factor alpha/genetics ; Receptor, Platelet-Derived Growth Factor alpha/metabolism ; Imatinib Mesylate/therapeutic use ; Eosinophils/pathology ; Oncogene Proteins, Fusion/genetics ; mRNA Cleavage and Polyadenylation Factors/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Activating STAT5B mutations can cause both primary hypereosinophilia and lymphocyte-variant hypereosinophilia.
Autorzy:
Umrau K; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Naganuma K; Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Gao Q; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Dogan A; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Kizaki M; Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Roshal M; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Liu Y; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Yabe M; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2023 Jan; Vol. 64 (1), pp. 238-241. Date of Electronic Publication: 2022 Oct 28.
Typ publikacji:
Letter
MeSH Terms:
Hypereosinophilic Syndrome*/diagnosis
Hypereosinophilic Syndrome*/genetics
Humans ; Gain of Function Mutation ; Lymphocytes ; STAT5 Transcription Factor/genetics
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Acute exacerbation of idiopathic hypereosinophilic syndrome following asymptomatic coronavirus disease 2019: a case report.
Autorzy:
Suzuki S; Department of General Internal Medicine, Asahikawa City Hospital, 1-65, Kinseicho-1-chome, Asahikawa, Hokkaido, Japan. .
Suzuki K; Department of General Internal Medicine, Asahikawa City Hospital, 1-65, Kinseicho-1-chome, Asahikawa, Hokkaido, Japan.
Ichikawa T; Department of Hematology, Asahikawa City Hospital, 1-65, Kinseicho-1-chome, Asahikawa, Hokkaido, Japan.
Takahashi K; Department of Neurology, Asahikawa City Hospital, 1-65, Kinseicho-1-chome, Asahikawa, Hokkaido, Japan.
Minami-Hori M; Department of Dermatology, Asahikawa City Hospital, 1-65, Kinseicho-1-chome, Asahikawa, Hokkaido, Japan.
Tanino Y; Department of Respiratory medicine, Asahikawa City Hospital, 1-65, Kinseicho-1-chome, Asahikawa, Hokkaido, Japan.
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2022 Aug 31; Vol. 16 (1), pp. 324. Date of Electronic Publication: 2022 Aug 31.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Autoimmune Diseases*/pathology
COVID-19*/complications
Churg-Strauss Syndrome*
Hypereosinophilic Syndrome*/complications
Hypereosinophilic Syndrome*/diagnosis
Hypereosinophilic Syndrome*/drug therapy
Antibodies, Antineutrophil Cytoplasmic ; Female ; Humans ; Lung/pathology ; Middle Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Imaging patterns of cerebral ischemia in hypereosinophilic syndrome: case report and systematic review.
Autorzy:
Miethe K; Department of Neurology, University Hospital, RTWH Aachen University, Pauwelsstr. 30, 52074, Aachen, Germany.
Iordanishvili E; Department of Diagnostic and Interventional Neuroradiology, University Hospital, RWTH Aachen University, Aachen, Germany.
Habib P; Department of Neurology, University Hospital, RTWH Aachen University, Pauwelsstr. 30, 52074, Aachen, Germany.; JARA-BRAIN Institute Molecular Neuroscience and Neuroimaging, Forschungszentrum Jülich GmbH and RWTH Aachen University, Aachen, Germany.
Panse J; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, University Hospital, RTWH Aachen University, Aachen, Germany.; Center for Integrated Oncology, Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany.
Krämer S; Department of Nephrology and Clinical Immunology, University Hospital, RTWH Aachen University, Aachen, Germany.
Wiesmann M; Department of Diagnostic and Interventional Neuroradiology, University Hospital, RWTH Aachen University, Aachen, Germany.
Schulz JB; Department of Neurology, University Hospital, RTWH Aachen University, Pauwelsstr. 30, 52074, Aachen, Germany.; JARA-BRAIN Institute Molecular Neuroscience and Neuroimaging, Forschungszentrum Jülich GmbH and RWTH Aachen University, Aachen, Germany.
Nikoubashman O; Department of Diagnostic and Interventional Neuroradiology, University Hospital, RWTH Aachen University, Aachen, Germany.
Reich A; Department of Neurology, University Hospital, RTWH Aachen University, Pauwelsstr. 30, 52074, Aachen, Germany.
Pinho J; Department of Neurology, University Hospital, RTWH Aachen University, Pauwelsstr. 30, 52074, Aachen, Germany. .
Pokaż więcej
Źródło:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2022 Aug; Vol. 43 (8), pp. 5091-5094. Date of Electronic Publication: 2022 May 19.
Typ publikacji:
Case Reports; Journal Article; Systematic Review
MeSH Terms:
Brain Ischemia*/complications
Brain Ischemia*/etiology
Hypereosinophilic Syndrome*/complications
Hypereosinophilic Syndrome*/diagnostic imaging
Ischemic Stroke*
Adult ; Female ; Humans ; Male ; Middle Aged ; Cerebral Infarction/complications ; Magnetic Resonance Imaging/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Myeloid neoplasm with ETV6::ACSl6 fusion: landscape of molecular and clinical features.
Autorzy:
Su Z; Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China.
Liu X; Department of Stem Cell Transplantation, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Hu W; Department of Hepatobiliary Surgery, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China.
Yang J; Department of Hematology Diagnosis Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China.
Yin X; Department of Hematology Diagnosis Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China.
Hou F; Department of Hematology Diagnosis Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China.
Wang Y; Department of Hematology Diagnosis Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China.
Zhang J; Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China.
Pokaż więcej
Źródło:
Hematology (Amsterdam, Netherlands) [Hematology] 2022 Dec; Vol. 27 (1), pp. 1010-1018.
Typ publikacji:
Case Reports; Journal Article; Review
MeSH Terms:
Hypereosinophilic Syndrome*
Leukemia, Myeloid, Acute*/genetics
Myeloproliferative Disorders*/genetics
Myeloproliferative Disorders*/pathology
Chromosome Aberrations ; Gene Fusion ; Humans ; Leukemia ; Receptor, Platelet-Derived Growth Factor beta/genetics
SCR Disease Name:
Pdgfra-Associated Chronic Eosinophilic Leukemia
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Topical tofacitinib for the management of lymphocytic-variant hypereosinophilic syndrome with cutaneous involvement.
Autorzy:
Said JT; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Elman SA; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Tawa M; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Fisher DC; Harvard Medical School, Boston, Massachusetts, USA.; Medical Oncology/Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Merola JF; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Division of Rheumatology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Kupper TS; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2022 Jul; Vol. 35 (7), pp. e15518. Date of Electronic Publication: 2022 May 17.
Typ publikacji:
Letter
MeSH Terms:
Hypereosinophilic Syndrome*/diagnosis
Hypereosinophilic Syndrome*/drug therapy
Humans ; Piperidines ; Pyrimidines
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Tumefactive eosinophil-rich non-granulomatous small vessel vasculitis in the cerebrum in a patient with idiopathic hypereosinophilic syndrome.
Autorzy:
Noro Y; Department of Neuropathology, Research Institute for Brain and Blood Vessels, Akita Cerebrospinal and Cardiovascular Center, Akita, Japan.; Akita University School of Medicine, Akita, Japan.
Miyata H; Department of Neuropathology, Research Institute for Brain and Blood Vessels, Akita Cerebrospinal and Cardiovascular Center, Akita, Japan.
Furuta T; Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
Sugita Y; Department of Pathology, Kurume University School of Medicine, Kurume, Japan.; Department of Neuropathology, St. Mary's Hospital, Kurume, Japan.
Suzuki Y; Department of Neurology, San-in Rosai Hospital, Yonago, Japan.
Kusumi M; Department of Neurology, San-in Rosai Hospital, Yonago, Japan.
Tanabe M; Department of Neurosurgery, San-in Rosai Hospital, Yonago, Japan.
Shomori K; Department of Pathology, San-in Rosai Hospital, Yonago, Japan.
Pokaż więcej
Źródło:
Neuropathology : official journal of the Japanese Society of Neuropathology [Neuropathology] 2022 Jun; Vol. 42 (3), pp. 239-244. Date of Electronic Publication: 2022 Apr 11.
Typ publikacji:
Case Reports
MeSH Terms:
Cerebrum*
Churg-Strauss Syndrome*/diagnosis
Epstein-Barr Virus Infections*
Granulomatosis with Polyangiitis*/diagnosis
Hypereosinophilic Syndrome*/complications
Aged ; Eosinophils ; Female ; Herpesvirus 4, Human ; Humans ; Paresis
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Korean Adolescent Patient with Manifestations of Lymphocyte Variant Hypereosinophilic Syndrome and Episodic Angioedema with Eosinophilia, Treated with Reslizumab.
Autorzy:
Jue JH; Department of Pediatrics, Keimyung University School of Medicine, Keimyung University Dongsan Hospital, Daegu, Korea. .
Shim YJ; Department of Pediatrics, Keimyung University School of Medicine, Keimyung University Dongsan Hospital, Daegu, Korea. .
Park S; Department of Laboratory Medicine, Keimyung University School of Medicine, Keimyung University Dongsan Hospital, Daegu, Korea. .
Kim DH; Department of Laboratory Medicine, Keimyung University School of Medicine, Keimyung University Dongsan Hospital, Daegu, Korea. .
Jung HR; Department of Pathology, Keimyung University School of Medicine, Keimyung University Dongsan Hospital, Daegu, Korea. .
Pokaż więcej
Źródło:
Iranian journal of allergy, asthma, and immunology [Iran J Allergy Asthma Immunol] 2022 Apr 11; Vol. 21 (2), pp. 215-218. Date of Electronic Publication: 2022 Apr 11.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Angioedema*/diagnosis
Angioedema*/drug therapy
Hypereosinophilic Syndrome*/diagnosis
Hypereosinophilic Syndrome*/drug therapy
Adolescent ; Antibodies, Monoclonal, Humanized ; Child ; Child, Preschool ; Eosinophils/pathology ; Female ; Humans ; Infant, Newborn ; Republic of Korea
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Bioprosthetic mitral valve stenosis secondary to hypereosinophilic syndrome.
Autorzy:
Quan X; Department of Echocardiography, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science, Peking Union Medical College, Beijing, China.
Song Y; Department of Adult Cardiac Surgery, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science, Peking Union Medical College, Beijing, China.
Wang H; Department of Pathology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science, Peking Union Medical College, Beijing, China.
Yang S; Department of Pathology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science, Peking Union Medical College, Beijing, China.
Zhu Z; Department of Echocardiography, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science, Peking Union Medical College, Beijing, China.
Pokaż więcej
Źródło:
Echocardiography (Mount Kisco, N.Y.) [Echocardiography] 2022 Apr; Vol. 39 (4), pp. 626-630. Date of Electronic Publication: 2022 Feb 26.
Typ publikacji:
Case Reports
MeSH Terms:
Heart Valve Prosthesis*
Heart Valve Prosthesis Implantation*
Hypereosinophilic Syndrome*/complications
Hypereosinophilic Syndrome*/diagnosis
Mitral Valve Insufficiency*/diagnostic imaging
Mitral Valve Insufficiency*/etiology
Mitral Valve Insufficiency*/surgery
Mitral Valve Stenosis*/complications
Mitral Valve Stenosis*/diagnostic imaging
Thrombosis*/complications
Humans ; Mitral Valve/diagnostic imaging ; Mitral Valve/surgery
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom.
Autorzy:
Requena G; Epidemiology, Value Evidence and Outcomes, Global R&D, GSK, London, UK.
Logie J; Real World Analytics, Value Evidence and Outcomes, Global Medical, GSK, London, UK.
Gibbons DC; Real World Analytics, Value Evidence and Outcomes, Global Medical, GSK, London, UK.
Steinfeld J; Respiratory Research & Development, GSK, Collegeville, Pennsylvania, USA.
Van Dyke MK; Epidemiology, Value Evidence and Outcomes, Global R&D, GSK, Collegeville, Pennsylvania, USA.
Pokaż więcej
Źródło:
Immunity, inflammation and disease [Immun Inflamm Dis] 2021 Dec; Vol. 9 (4), pp. 1447-1451. Date of Electronic Publication: 2021 Jul 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hypereosinophilic Syndrome*/diagnosis
Hypereosinophilic Syndrome*/epidemiology
Databases, Factual ; Humans ; Incidence ; Prevalence ; United Kingdom/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Recurrent prosthetic valve dysfunction in a patient with idiopathic hypereosinophilic syndrome: A case report and literature review.
Autorzy:
Wei Z; Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung, and Blood Vascular Diseases, Beijing, China.
Guo H; Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung, and Blood Vascular Diseases, Beijing, China.
Li J; Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung, and Blood Vascular Diseases, Beijing, China.
Lai Y; Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung, and Blood Vascular Diseases, Beijing, China.
Pokaż więcej
Źródło:
Journal of cardiac surgery [J Card Surg] 2021 Nov; Vol. 36 (11), pp. 4400-4402. Date of Electronic Publication: 2021 Aug 21.
Typ publikacji:
Case Reports; Review
MeSH Terms:
Bioprosthesis*
Heart Valve Prosthesis*
Heart Valve Prosthesis Implantation*
Hypereosinophilic Syndrome*/complications
Hypereosinophilic Syndrome*/surgery
Mitral Valve Stenosis*/surgery
Humans ; Mitral Valve/diagnostic imaging ; Mitral Valve/surgery ; Reoperation
Recenzja
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Central Nervous System and Cardiac Involvement in the Hypereosinophilic Syndrome: A Case Report.
Autorzy:
Kiani R; Department of adult cardiology, Rajaie Cardiovascular Medical and Research Center, Tehran, Iran.
Naghavi B; Department of adult cardiology, Rajaie Cardiovascular Medical and Research Center, Tehran, Iran.
Amin A; Department of adult cardiology, Rajaie Cardiovascular Medical and Research Center, Tehran, Iran.
Sadeghpour A; Department of adult cardiology, Rajaie Cardiovascular Medical and Research Center, Tehran, Iran.
Zahedmehr A; Department of adult cardiology, Rajaie Cardiovascular Medical and Research Center, Tehran, Iran.
Firouzi A; Department of adult cardiology, Rajaie Cardiovascular Medical and Research Center, Tehran, Iran.
Pouraliakbar HR; Department of adult cardiology, Rajaie Cardiovascular Medical and Research Center, Tehran, Iran.
Ebrahimi Meymand S; Department of adult cardiology, Rajaie Cardiovascular Medical and Research Center, Tehran, Iran.
Marashizadeh A; Department of internal medicine, Iran University of Medical Sciences, Tehran, Iran.
Almasi S; Department of internal medicine, Iran University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło:
Immunological investigations [Immunol Invest] 2021 May; Vol. 50 (4), pp. 356-362. Date of Electronic Publication: 2020 Jul 27.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Brain*/diagnostic imaging
Brain*/pathology
Cardiac Tamponade*/diagnostic imaging
Cardiac Tamponade*/pathology
Cardiac Tamponade*/physiopathology
Heart Ventricles*/diagnostic imaging
Heart Ventricles*/pathology
Heart Ventricles*/physiopathology
Hypereosinophilic Syndrome*/diagnostic imaging
Hypereosinophilic Syndrome*/pathology
Hypereosinophilic Syndrome*/physiopathology
Female ; Humans ; Middle Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A case of hypereosinophilic syndrome with Loeffler endocarditis successfully bridged to heart transplantation by biventricular mechanical support.
Autorzy:
Di Nora C; Department of Cardiothoracic Science, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
De Gaspari M; Pathological Anatomy Unit, Department of Medical Area (DAME), University of Udine, Udine, Italy.
Livi U; Department of Cardiothoracic Science and Department of Medical Area DAME, University of Udine, Udine, Italy.
Pokaż więcej
Źródło:
Artificial organs [Artif Organs] 2021 Jul; Vol. 45 (7), pp. 784-785. Date of Electronic Publication: 2021 Jan 26.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Heart-Assist Devices*
Hypereosinophilic Syndrome/*diagnosis
Hypereosinophilic Syndrome/*drug therapy
Adult ; Endocarditis ; Heart Transplantation ; Humans ; Hypereosinophilic Syndrome/surgery ; Male ; Treatment Outcome
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 250

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies